Clinical and Molecular profiling of KRAS G12C lung adenocarcinomas

被引：0
|
作者：
Bulusu, Venkata [1 ]
Jessop, Susan [2 ]
Paul, Sherin [2 ]
Chapman, Timothy [2 ]
Ben-Gashir, Mohamed [2 ]
Geetha, Anil [2 ]
Punnen, Geethu [2 ]
Aslam, Shahzeena [2 ]
Hutka, Margaret [2 ]
机构：
[1] Bedford Hosp, Primrose Oncol Unit, Bedford, England
[2] Bedford Hosp, Bedford, England
来源：
LUNG CANCER | 2023年 / 178卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
41
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [21] Notch activation drives resistance to Kras(G12C) inhibition in lung adenocarcinoma
    Hwang, Elizabeth E.
    Lee, Alex
    Leung, Stanley
    Breese, Marcus
    Sweet-Cordero, Alejandro
    CANCER RESEARCH, 2022, 82 (12)
  • [22] EGFR/KRAS Mutational Profiling of Lung Adenocarcinomas in a Clinical Practice
    Dacic, S.
    Yousem, S. A.
    Ohori, P. N.
    Nikiforova, M.
    MODERN PATHOLOGY, 2009, 22 : 352A - 352A
  • [23] EGFR/KRAS Mutational Profiling of Lung Adenocarcinomas in a Clinical Practice
    Dacic, S.
    Yousem, S. A.
    Ohori, P. N.
    Nikiforova, M.
    LABORATORY INVESTIGATION, 2009, 89 : 352A - 352A
  • [24] KRAS G12C mutation is prognostic of poor outcome in resected lung adenocarcinomas and predictive of poor response to MEK inhibition in vitro.
    Nadal, Ernest
    Shiratsuchi, Hiroe
    Chen, Guoan
    Sam, Christine
    Kalemkerian, Gregory P.
    Beer, David G.
    Ramnath, Nithya
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [25] Development of inhibitors of the activated form of KRAS G12C
    Pollock, R.
    Stewart, M.
    Perl, N.
    Lee, S. J.
    Xue, L.
    Zhou, M.
    Simon, J.
    Luly, K.
    Grigoriu, S.
    Yuzhakov, A.
    Silver, A.
    Lowe, J.
    Mann, A.
    Verdine, G.
    Rigby, A.
    Mulvihill, M.
    May, E.
    Kohlmann, A.
    Townson, S.
    Jin, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E52 - E52
  • [26] KRAS (G12C) mediated mRNA translation program
    Singh, Kamini
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [27] Covalent Guanosine Mimetic Inhibitors of G12C KRAS
    Xiong, Yuan
    Lu, Jia
    Hunter, John
    Li, Lianbo
    Scott, David
    Choi, Hwan Geun
    Lim, Sang Min
    Manandhar, Anuj
    Gondi, Sudershan
    Sim, Taebo
    Westover, Kenneth D.
    Gray, Nathanael S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (01): : 61 - 66
  • [28] The emerging target KRAS G12C in genitourinary malignancies
    Grivas, Petros
    Necchi, Andrea
    Bratslavsky, Gennady
    Shapiro, Oleg
    Jacob, Joseph
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Killian, Keith
    Williams, Erik
    Ramkissoon, Shakti H.
    Severson, Eric Allan
    Hemmerich, Amanda
    Schrock, Alexa Betzig
    Chung, Jon
    McGregor, Kimberly
    Reddy, Prasanth
    Alexander, Brian Michael
    Sokol, Ethan
    Danziger, Natalie
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [29] Two new agents target KRAS G12C
    Diana Romero
    Nature Reviews Clinical Oncology, 2020, 17 (1) : 6 - 6
  • [30] LANDSCAPE OF KRAS G12C MUTATIONS IN GENITOURINARY MALIGNANCIES
    Rebecca, Sager A.
    Michael, Basin F.
    Hanan, Goldberg
    Jeffrey, Ross S.
    Gennady, Bratslavsky
    Joseph, Jacob M.
    Petros, Grivas
    Andrea, Necchi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S69 - S69
12345